DSP Healthcare Fund vs Nippon India Pharma Fund compare
Nippon India Pharma Fund-Growth Plan-Growth Option
DSP Healthcare Fund - Regular Plan - Growth
Chart Comparison
Overview
| Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | DSP Healthcare Fund - Regular Plan - Growth |
|---|---|---|
| Fund | Nippon India Pharma Fund-Growth Plan-Growth Option | DSP Healthcare Fund - Regular Plan - Growth |
| Investment Plan | Growth | Growth |
| Level of Risk | Very High | Very High |
| Asset Size (Cr) | ₹8346 Cr | ₹3144 Cr |
| Min Investment | ₹5000 | ₹100 |
| Min SIP Invesment | ₹500 | ₹100 |
| Min Addl Investment | ₹1000 | ₹100 |
| Launch Date | 05 Jun 2004 | 30 Nov 2018 |
| Category | Pharma & Healthcare | Pharma & Healthcare |
| Fund Type | Open Ended | Open Ended |
| Benchmark | BSE Healthcare | BSE Healthcare |
| Turn Over | 21% | 18% |
| Expense Ratio | 1.82 | 1.9 |
| Manager | Sailesh Raj Bhan | Jay Kothari |
| ISIN Code | INF204K01968 | INF740KA1LD8 |
| Exits Load | Nippon India Pharma Fund - Growth charges 1.0% of sell value; if fund sold before 30 days. There are no other charges./365 | DSP Healthcare Fund - Regular Plan - Growth charges 0.5% of sell value; if fund sold before 30 days. There are no other charges./365 |
Trailing Lumpsum Returns
| Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | DSP Healthcare Fund - Regular Plan - Growth |
|---|---|---|
| 1 Month | 1.53% | 1.41% |
| 6 Month | 3.31% | 5.57% |
| 1 Year | 3.77% | -2.2% |
| 3 Year | 21.72% | 21.48% |
| 5 Year | 16.93% | 17% |
SIP Return Analysis
| Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | DSP Healthcare Fund - Regular Plan - Growth |
|---|---|---|
| 6 Month | 0.99% | 1.8% |
| 1 Year | 8.09% | 7.37% |
| 3 Year | 18.15% | 18.52% |
| 5 Year | 17.13% | 17.73% |
Rolling Lumpsum Returns
| Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | DSP Healthcare Fund - Regular Plan - Growth |
|---|---|---|
| 1 Year | 16.72% | 24.33% |
| 3 Year | 20.9% | 21.38% |
| 5 Year | 20.42% | 25.77% |
Risk Management
| Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | DSP Healthcare Fund - Regular Plan - Growth |
|---|---|---|
| Standard Deviation | 14.36% | 14.63% |
| Sharp | 0.95% | 0.98% |
| Beta | 0.87% | 0.84% |
| Alpha | 1.94% | 1.19% |
Fund Managers
| Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | DSP Healthcare Fund - Regular Plan - Growth |
|---|---|---|
| Name | Sailesh Raj Bhan | Jay Kothari |
| Total AUM | ₹96086 Cr | ₹0 Cr |
| Funds Managed | 5 | 20 |
| Nippon India Pharma Fund-Growth Plan-Growth Option | DSP Healthcare Fund - Regular Plan - Growth |
Market Cap
| Scheme Name |
Nippon India Pharma Fund-Growth Plan-Growth Option |
DSP Healthcare Fund - Regular Plan - Growth |
|---|---|---|
| Others | 1.24 | 16.7 |
| Large Cap | 32.65 | 16.81 |
| Mid Cap | 35.11 | 13.8 |
| Small Cap | 31 | 52.69 |
Sector Allocation
| Scheme Name |
Nippon India Pharma Fund-Growth Plan-Growth Option |
DSP Healthcare Fund - Regular Plan - Growth |
|---|---|---|
| Others | 0.34 | 2.09 |
| Healthcare | 99.66 | 96.38 |
| Financial Services | - | 1.53 |
Top Comparisons
Mahindra Manulife Multi Cap Fund - Regular Plan - Growth
3Y Returns19.06%
DSP Multicap Fund - Regular (G)
3Y Returns0%
Mahindra Manulife Aggressive Hybrid Fund - Regular Plan - Growth
3Y Returns16.16%
Bandhan Aggressive Hybrid Fund - Growth
3Y Returns15.26%
DSP Savings Fund - Regular Plan - Growth
3Y Returns7.23%
UTI MMF-Discontinued - Regular Plan -Growth
3Y Returns7.25%
PGIM India Corporate Bond Fund - Growth
3Y Returns7.27%
Canara Robeco CorpoRate Bond Fund - Regular Plan - Growth Option
3Y Returns6.69%